SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001169245-22-000093
Filing Date
2022-08-12
Accepted
2022-08-12 08:36:00
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q phas-20220630.htm   iXBRL 10-Q 1591512
2 EX-10.1 ex101-2018equityincentivep.htm EX-10.1 41117
3 EX-31.1 ex311-phas10xq2022q2.htm EX-31.1 10327
4 EX-31.2 ex312-phas10xq2022q2.htm EX-31.2 10321
5 EX-32.1 ex-321xphas10xq2022q2.htm EX-32.1 4741
6 EX-32.2 ex-322xphas10xq2022q2.htm EX-32.2 4737
  Complete submission text file 0001169245-22-000093.txt   6010620

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phas-20220630.xsd EX-101.SCH 45882
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT phas-20220630_cal.xml EX-101.CAL 51427
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT phas-20220630_def.xml EX-101.DEF 190642
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phas-20220630_lab.xml EX-101.LAB 503651
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phas-20220630_pre.xml EX-101.PRE 326835
63 EXTRACTED XBRL INSTANCE DOCUMENT phas-20220630_htm.xml XML 750454
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 221157955
SIC: 2834 Pharmaceutical Preparations